By coincidence last week, as we posted about wrinkle fillers with lidocaine, Allergan
was announcing FDA clearance for the new Juvederm Ultra XC. The company is citing results from their clinical trial in which 93 percent of patients reported reduced pain with the new formulation. They are now marketing Juvederm XC as a comfortable alternative to regular Juvederm.
Facts to know about Juvederm XC
- Contains a small amount (0.3%) of local anesthetic
- Composed of colorless hyaluronic acid – a hydrator and cushioning agent
- Results last about 9 -12 months
- Those allergic to lidocaine or Gram-positive bacterial proteins should not use Juvederm XC
- Traditional pain control methods can still be used to further minimize discomfort
- Safety profile and frequency of side effects is very similar to non-lidocaine Juvederm
As we 
Although the economic news this week is looking optimistic, the job market is still a rough environment to navigate. We’ve had more than one patient comment about it and share suspicions about age, or appearance, negatively affecting job prospects. My neighbor told me last week that her job interviews hadn’t gone as well as she’d hoped and her explanation was, “if it isn’t my qualifications, it must be the crow’s feet.”
Many of us in the industry probably remember when collagen first received FDA approval over 20 years ago. People considering it at the time were hopeful about looking better, but scared about allergic reactions, painful injections, and swelling. In 2009, we have a wider variety of fillers to choose from that are safe and effective.
